Rocket Lab 2 January 2026 - 16 January 2026

Morgan Stanley upgraded Rocket Lab to “overweight” and raised its price target from $67 to $105, sending shares up 6% to $96 on Friday. KeyBanc downgraded the stock to “sector weight,” citing valuation concerns and uncertainty over the Neutron rocket’s launch timeline. Investors are watching Neutron’s inaugural flight as Rocket Lab’s market cap hit $48 billion.

Rocket Lab shares fell 1.13% to $90.76 Thursday and slipped another 0.53% after hours after KeyBanc downgraded the stock to “sector weight,” citing that recent gains are already priced in. Director Merline Saintil disclosed selling over 108,000 shares this week in SEC filings.

Rocket Lab shares fell 4.3% to $87.90 in early trading Thursday after KeyBanc downgraded the stock to “sector weight” and removed its price target. The move follows a month-long surge of 63%. KeyBanc cited balanced risk-reward and flagged uncertainty over Neutron’s launch schedule. Investors now await Rocket Lab’s earnings report on Feb. 26.

Rocket Lab shares dropped 2.2% to $89.81 in premarket trading Thursday after KeyBanc downgraded the stock to “sector weight,” citing valuation and widely known growth drivers. The move follows a volatile stretch and recent gains. Investors now await Rocket Lab’s quarterly results, expected in late February.

Rocket Lab shares climbed 3.5% Wednesday, nearing a 52-week high around $90.49, while the Nasdaq slipped. Baird raised its price target to $100, citing a $1 billion-plus U.S. defense contract. The stock has surged from the mid-teens over the past year. Rocket Lab reports earnings Feb. 26.

Rocket Lab shares rose 0.1% to $87.98 by midday Tuesday after Baird raised its price target to $100, citing a recent $816 million U.S. defense satellite contract. The stock traded on heavy volume as investors focused on execution risks and the company’s upcoming earnings. Rocket Lab’s revenue surged 52% over the past year, but it remains unprofitable.

Rocket Lab shares climbed 4.6% to $86.87 Friday morning after SEC filings showed CFO Adam Spice sold $103.1 million in stock and COO Frank Klein sold $7.3 million, both under preset 10b5-1 plans. Shares had dropped 1.2% Thursday following the insider sales. Investors are watching for the next earnings update and any changes to the Neutron rocket timetable.

Rocket Lab shares fell 1.2% to $83.08 and slipped further after hours following news that CFO Adam Spice sold about 1.37 million shares for $103 million under a preset plan, according to an SEC filing. The company is valued at $44.4 billion. Investors await Friday’s U.S. jobs report and Rocket Lab’s Feb. 26 earnings.

Rocket Lab shares slipped 0.2% to $83.93 in premarket trading after SEC filings showed CFO Adam Spice and COO Frank Klein sold shares under preset 10b5-1 plans. Spice sold 1,365,665 shares on Jan. 5, while Klein sold 100,000 shares on Jan. 2. The stock had dropped 2.3% Wednesday after a 10% surge Tuesday. Investors await the next earnings update and Neutron development news.

Rocket Lab shares fell 1.8% Wednesday after an SEC filing showed COO Frank Klein sold 100,000 shares under a pre-set plan. The stock traded at $84.50 by 10:54 a.m. EST, near its 52-week high, with a market value of $44.2 billion. Klein still holds over 1.1 million shares. Investors await the next earnings report, expected late February.

Rocket Lab shares fell 2.6% to $83.80 Wednesday after filings showed CFO Adam Spice and COO Frank Klein sold about $110 million in stock under preset plans. The sales followed a sharp rally and came as Rocket Lab trades near a 52-week high. Spice sold 1.37 million shares for $103.1 million, while Klein sold 100,000 shares for $7.3 million. Both sales were disclosed in SEC Form 4 filings.

Rocket Lab shares jumped 8.9% to $75.99 Friday after a late SEC filing showed COO Frank Klein plans to sell up to 100,000 shares under a 10b5-1 plan. The stock traded as high as $76.24 on volume of 31.4 million shares. Investors are watching for updates on Neutron rocket milestones and the next earnings report.

Rocket Lab shares surged 8.9% to $75.99 Friday, then edged down 0.3% after hours. Volume topped 31.2 million shares, about 17% above average. The move followed recent analyst target hikes and a late-2025 $816 million satellite contract. The stock traded near its 52-week high, with no new company announcement issued.

Rocket Lab shares rose 1.4% to $70.75 by 11:12 a.m. ET Friday, following a volatile period and renewed debate over cash burn after a bearish analyst note. Investors are watching for updates on the Neutron rocket and the next earnings report, expected in late February.